Tibor Keler.
2013
In 2013, Tibor Keler. earned a total compensation of $1.8M as Executive Vice President and Chief Scientific Officer at Celldex Therapeutics, a 89% increase compared to previous year.
Compensation breakdown
| Bonus | $186,000 |
|---|---|
| Option Awards | $1,207,615 |
| Salary | $367,484 |
| Other | $3,651 |
| Total | $1,764,750 |
Keler received $1.2M in option awards, accounting for 68% of the total pay in 2013.
Keler also received $186K in bonus, $367.5K in salary and $3.7K in other compensation.
Rankings
In 2013, Tibor Keler.'s compensation ranked 4,315th out of 12,286 executives tracked by ExecPay. In other words, Keler earned more than 64.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,315 out of 12,286 | 65th |
Division Manufacturing | 1,475 out of 4,612 | 68th |
Major group Chemicals And Allied Products | 413 out of 1,462 | 72nd |
Industry group Drugs | 284 out of 1,156 | 75th |
Industry In Vitro and In Vivo Diagnostic Substances | 14 out of 56 | 75th |
Source: SEC filing on April 21, 2016.
Keler's colleagues
We found four more compensation records of executives who worked with Tibor Keler. at Celldex Therapeutics in 2013.
News
Celldex Therapeutics CEO Anthony Marucci's 2021 pay jumps 101% to $6M
April 26, 2022
Celldex Therapeutics CEO Anthony Marucci's 2020 pay jumps 166% to $3M
April 27, 2021
Celldex Therapeutics CEO Anthony Marucci's 2019 pay slips 19% to $1.1M
April 28, 2020
Celldex Therapeutics CEO Anthony Marucci's 2018 pay slips 17% to $1.4M
April 26, 2019